Humacyte Inc (NASDAQ: HUMA) on Friday, soared 7.45% from the previous trading day, before settling in for the closing price of $1.61. Within the past 52 weeks, HUMA’s price has moved between $1.15 and $6.77.
During the last 5-year period, the sales growth of Healthcare Sector giant was 42.43%. The company achieved an average annual earnings per share of 70.20%. With a float of $131.52 million, this company’s outstanding shares have now reached $156.34 million.
Humacyte Inc (HUMA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Humacyte Inc is 17.20%, while institutional ownership is 36.62%. The most recent insider transaction that took place on Aug 19 ’25, was worth 1,793,000. In this transaction Director of this company sold 1,100,000 shares at a rate of $1.63, taking the stock ownership to the 591,685 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Director sold 549,360 for $1.83, making the entire transaction worth $1,005,329. This insider now owns 1,691,685 shares in total.
Humacyte Inc (HUMA) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.26 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.25) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 70.20% per share during the next fiscal year.
Humacyte Inc (NASDAQ: HUMA) Trading Performance Indicators
Humacyte Inc (HUMA) is currently performing well based on its current performance indicators. A quick ratio of 1.93 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 335.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Humacyte Inc (HUMA)
Looking closely at Humacyte Inc (NASDAQ: HUMA), its last 5-days average volume was 3.06 million, which is a drop from its year-to-date volume of 3.94 million. As of the previous 9 days, the stock’s Stochastic %D was 46.30%.
During the past 100 days, Humacyte Inc’s (HUMA) raw stochastic average was set at 31.43%, which indicates a significant decrease from 63.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1180 in the past 14 days, which was lower than the 0.1829 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8677, while its 200-day Moving Average is $2.6852. However, in the short run, Humacyte Inc’s stock first resistance to watch stands at $1.7833. Second resistance stands at $1.8367. The third major resistance level sits at $1.9333. If the price goes on to break the first support level at $1.6333, it is likely to go to the next support level at $1.5367. Now, if the price goes above the second support level, the third support stands at $1.4833.
Humacyte Inc (NASDAQ: HUMA) Key Stats
Market capitalization of the company is 274.79 million based on 158,372K outstanding shares. Right now, sales total 0 K and income totals -148,700 K. The company made 300 K in profit during its latest quarter, and -37,660 K in sales during its previous quarter.
